ITRM - Iterum aims for early ORLYNVAH launch in August 2025 and eyes expansion in $40M uUTI market
2025-08-05 16:59:18 ET
More on Iterum Therapeutics
- Iterum Therapeutics plc (ITRM) Q2 2025 Earnings Call Transcript
- Iterum Therapeutics plc (ITRM) Q1 2025 Earnings Call Transcript
- Iterum Therapeutics Non-GAAP EPS of -$0.13
- Iterum targets ORLYNVAH US launch by Q4 2025 while extending cash runway into 2026
- Seeking Alpha’s Quant Rating on Iterum Therapeutics